Impact of active pulmonary tuberculosis on the prognosis of patients with upper aerodigestive cancers: An 8-year observational study in a nationwide cohort

被引:0
|
作者
Hung, Chung-Lin [1 ]
Su, Chien-Chou [2 ]
Ou, Chih-Ying [3 ,4 ]
机构
[1] Dalin Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Dept Internal Med, Div Hematol Oncol, Chiayi, Taiwan
[2] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Clin Innovat & Res Ctr, Tainan, Taiwan
[3] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Dept Internal Med,Div Chest Med,Dou Liou Branch, Yunlin, Taiwan
[4] Natl Cheng Kung Univ Hosp, Dept Internal Med, Div Chest Med, Dou Liou Branch, Yunlin, Taiwan
关键词
Head and neck neoplasms; Incidence; Mortality; Risk factors; Tuberculosis; ESOPHAGEAL CANCER; RISK-FACTORS; MORTALITY; DEATH; HEAD; SURVIVAL; DISEASE; LUNG;
D O I
10.1016/j.jiph.2022.11.003
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background and objective: Tuberculosis (TB), a contagious disease with high morbidity and mortality, is prevalent among immunocompromised patients including those with cancers. We describe the risk subgroups and impact of active TB on the prognosis of patients with upper aerodigestive cancers.Methods: We conducted a retrospective, nationwide cohort study from January 2009 to December 2014, and followed up until the end of 2016, using the database of the Taiwanese National Health Insurance (NHI) program. Patients newly diagnosed with oral, nasopharyngeal, laryngeal, and esophageal cancers were defined as the upper aerodigestive cancer cohort. Active pulmonary TB infection was identified as a time dependent variable in the analysis of the risk subgroups and prognostic impact in our study cohort.Results: A total of 57,543 patients were enrolled, and 890 patients (1.55 %) had active pulmonary TB during the follow-up period. The TB incidence was highest in patients with esophageal cancer and lowest in patients with nasopharyngeal cancer (1443 and 236 per 100, 000 person-years, respectively). Moreover, advanced cancer stage and inoperable cancer are considered risk factors for TB. Furthermore, patients with TB infection had a shorter survival (HR: 1.86, 95 % CI: 1.70-2.04), after matching cancer type, stage, and calendar year of diagnosis with patients without TB.Conclusion: Active pulmonary TB is prevalent in patients with upper aerodigestive cancers and is independently associated with an increased risk of death. Identifying the risk factors for TB in these cancer patients is important both for infectious disease control and outcome evaluation.(c) 2022 The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页码:1540 / 1545
页数:6
相关论文
共 50 条
  • [21] Comparable outcomes of decompensated chronic hepatitis B patients treated with entecavir or tenofovir: an 8-year cohort study
    Lee, Kuan-Chieh
    Cheng, Jur-Shan
    Chang, Ming-Ling
    Chien, Rong-Nan
    Liaw, Yun-Fan
    HEPATOLOGY INTERNATIONAL, 2022, 16 (04) : 799 - 806
  • [22] The Impact of Sildenafil on Ischemic Outcomes in Patients with Pulmonary Hypertension - A Nationwide Cohort Study
    Chang, Wei-Ting
    Su, Chien-Chou
    Chang, Yu-Ching
    Cheng, Ching-Lan
    Hsu, Chih-Hsin
    ACTA CARDIOLOGICA SINICA, 2022, 38 (05) : 623 - 630
  • [23] Association of Weight Gain and Metabolic Syndrome in Patients Taking Clozapine: An 8-Year Cohort Study
    Bai, Ya Mei
    Lin, Chao-Cheng
    Chen, Jen-Yeu
    Chen, Tzu Ting
    Su, Tung-Pine
    Chou, Pesus
    JOURNAL OF CLINICAL PSYCHIATRY, 2011, 72 (06) : 751 - 756
  • [24] Incidence, risk factors and impact on outcomes of secondary infection in patients with septic shock: an 8-year retrospective study
    Zhao, Guang-ju
    Li, Dong
    Zhao, Qian
    Song, Jia-xing
    Chen, Xiao-rong
    Hong, Guang-liang
    Li, Meng-fang
    Wu, Bing
    Lu, Zhong-qiu
    SCIENTIFIC REPORTS, 2016, 6
  • [25] Incidence and Predictors of Adverse Drug Events Among People Receiving Drug Resistant Tuberculosis Treatment in Uganda: 8-Year Retrospective Cohort Study
    Nasasira, Marble
    Kalyango, Joan N.
    Mupere, Ezekiel
    Baluku, Joseph Baruch
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2022, 18 : 1117 - 1127
  • [26] Long-term Mortality of a Cohort of Patients Undergoing Surgical Treatment for Diabetic Foot Infections. An 8-year Follow-up Study
    Aragon-Sanchez, Javier
    Viquez-Molina, Gerardo
    Lopez-Valverde, Maria Eugenia
    Aragon-Hernandez, Javier
    Rojas-Bonilla, Jose Maria
    Murillo-Vargas, Christian
    INTERNATIONAL JOURNAL OF LOWER EXTREMITY WOUNDS, 2023, 22 (02): : 314 - 320
  • [27] Factors Associated with Death during Tuberculosis Treatment of Patients Co-Infected with HIV at the Yaounde Central Hospital, Cameroon: An 8-Year Hospital-Based Retrospective Cohort Study (2006-2013)
    Agbor, Ako A.
    Bigna, Jean Joel R.
    Billong, Serges Clotaire
    Tejiokem, Mathurin Cyrille
    Ekali, Gabriel L.
    Plottel, Claudia S.
    Noubiap, Jean Jacques N.
    Abessolo, Hortence
    Toby, Roselyne
    Koulla-Shiro, Sinata
    PLOS ONE, 2014, 9 (12):
  • [28] Impact of Diabetes on the Recurrence and Prognosis of Acute Kidney Injury in Older Male Patients: A 10-Year Retrospective Cohort Study
    Shen, Xin
    Lv, Kunming
    Hou, Baicun
    Ao, Qiangguo
    Zhao, Jiahui
    Yang, Guang
    Cheng, Qingli
    DIABETES THERAPY, 2022, 13 (11-12) : 1907 - 1920
  • [29] Impact of Pulmonary Ventilation Dysfunction on Prognosis of Patients with Coronary Artery Disease: A Single-Center, Observational Study
    Li, Yu-Shan
    Ren, Qiang
    Zhang, Jian
    Liang, Yan-Chun
    Han, Ya-Ling
    Zhang, Quan-Yu
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2024, 25 (06)
  • [30] Tuberculosis incidence in country of origin is a key determinant of the risk of active tuberculosis in people living with HIV: Data from a 30-year observational cohort study
    White, Helena A.
    Okhai, Hajra
    Kirwan, Peter
    Rafeeq, Sonia H.
    Dillon, Helen
    Hefford, Phillip
    Wiselka, Martin J.
    Pareek, Manish
    HIV MEDICINE, 2022, 23 (06) : 650 - 660